NVS
Novartis AG ADRNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$282.11B
P/E Ratio
21.18
EPS
$6.98
Beta
0.52
52W High
$165.43
52W Low
$101.83
50-Day MA
$154.50
200-Day MA
$137.39
Dividend Yield
3.21%
Profit Margin
23.90%
Forward P/E
15.90
PEG Ratio
2.48
About Novartis AG ADR
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Fundamentals
| Revenue (TTM) | $56.58B |
| Gross Profit (TTM) | $42.75B |
| EBITDA | $22.92B |
| Operating Margin | 30.50% |
| Return on Equity | 34.90% |
| Return on Assets | 10.50% |
| Revenue/Share (TTM) | $29.40 |
| Book Value | $24.18 |
| Price-to-Book | 7.08 |
| Price-to-Sales (TTM) | 4.99 |
| EV/Revenue | 5.55 |
| EV/EBITDA | 14.02 |
| Quarterly Earnings Growth (YoY) | -9.30% |
| Quarterly Revenue Growth (YoY) | -0.70% |
| Shares Outstanding | $1.91B |
| Float | $1.82B |
| % Insiders | 0.00% |
| % Institutions | 7.11% |
Historical Volatility
HV 10-Day
26.35%
HV 20-Day
21.46%
HV 30-Day
21.20%
HV 60-Day
20.99%
HV Rank
65.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($153.56 target)
2
Strong Buy2
Buy5
Hold2
SellData last updated: 5/1/2026